15 Mar Race/ethnicity are underrepresented in dermatology trials

By Rob Dillard, Urban Health Today

A study assessed the racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis (AD), and psoriasis. The analysis appeared in the The Journal of Dermatalogical Treatment.

In this study, researchers reviewed clinical trials for common dermatologic conditions published between January 2014 and July 2019. They compared race/ethnicity reporting among the trials to skin disease, mode of intervention, and trial phase. Overall, they assessed 103 articles from 119 trials.

The study found that White participants represented 77.5% of the U.S. population, a number largely driven by psoriasis trials (72.5%). Read more …